American Liver Foundation
-
Madrigal Pharmaceuticals in Conshohocken Reports $14.6 Million in Sales from Groundbreaking NASH Drug Rezdiffra
Conshohocken-based Madrigal Pharmaceuticals generated $14.6 million in sales from Rezdiffra, its first and flagship product, during the second quarter of…
-
Madrigal Pharmaceuticals Sells $500M in Stocks in Prep for FDA Approval
Conshohocken-based Madrigal Pharmaceuticals is in a flurry of activity as it prepares for the potential launch of its NASH drug…
Founding Partners
Advertisement
Affiliate Partners
Community Partners
